Understanding the role of the IL-2 – IL-2R pathway in autoimmune diseases like MS is further complicated by the existence of soluble (s)IL-2R, a receptor component most likely released by shedding from the cell surface of activated immune cells. This evidence concerns the gene IL2 and myeloid sarcoma.